"The U.S. Food and Drug Administration today approved Taltz (ixekizumab) to treat adults with moderate-to-severe plaque psoriasis.
Psoriasis is a skin condition that causes patches of skin redness and flaking. Psoriasis is an autoimm"...
Taclonex® Topical Suspension is indicated for the topical treatment of plaque psoriasis of the scalp and body in patients 18 years and older.
DOSAGE AND ADMINISTRATION
Usual Dosage And Administration
Apply Taclonex® Topical Suspension to affected areas once daily for up to 8 weeks. Treatment may be discontinued earlier, if cleared.
Instruct patients not to exceed a maximum weekly dose of 100 g.
Important Administration Instructions
Instruct patients to shake bottle prior to using Taclonex® Topical Suspension and to wash their hands after applying the product. Taclonex® Topical Suspension is not for oral, ophthalmic, or intravaginal use.
Dosage Forms And Strengths
Topical Suspension, 0.005%/0.064% Each gram of Taclonex® Topical Suspension contains 52.18 mcg of calcipotriene hydrate (equivalent to 50 mcg of calcipotriene) and 0.643 mg of betamethasone dipropionate (equivalent to 0.5 mg of betamethasone). Taclonex® Topical Suspension is a viscous, nearly odorless, almost clear, colorless to slightly off-white suspension.
Storage And Handling
Taclonex® Topical Suspension is a viscous, nearly odorless, almost clear, colorless to slightly off-white suspension. It is available in bottles of:
60 g (NDC 50222-501-06)
120 g (2 bottles of 60 g) (NDC 50222-501-66)
Store between 20°C-25°C (68°F-77°F); excursions permitted between 15°C-30°C (59°F-86°F). [See USP controlled room temperature.]
Do not refrigerate. Keep the bottle in the outer carton when not in use.
The product should be used within six months after it has been opened.
Shake before use. Keep out of reach of children
Manufactured by: LEO Laboratories Ltd. (LEO Pharma) 285 Cashel Road. Distributed by: LEO Pharma Inc. 1 Sylvan Way, Parsippany, NJ 07054, USA. Revised: July 2014This monograph has been modified to include the generic and brand name in many instances.
Last reviewed on RxList: 8/11/2014
Additional Taclonex Scalp Information
Taclonex Scalp - User Reviews
Taclonex Scalp User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.